US 11306150
Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist
granted A61KA61K45/06A61P
Quick answer
US patent 11306150 (Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist) held by Five Prime Therapeutics, Inc. expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00